Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A commercial vaccine refers to any vaccine that is available for purchase and produced for widespread use to combat infectious diseases. These vaccines are typically developed and manufactured by pharmaceutical companies and are subject to regulatory approval. They often require specific storage conditions, such as cold storage, which can sometimes limit their distribution and use in remote areas. In scientific literature, 'commercial vaccine 1' is frequently used as a placeholder to refer to a specific, commercially available vaccine being used as a control or comparator in a study, rather than denoting a single, universally recognized product. Examples include Nobilis® Salenvac T for Salmonella in hens, ProteqFlu for equine influenza, and Suvaxyn® Gold PCV MH for porcine circovirus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Commercial vaccine.